In ESCC, at least seven independent studies have examined LC3 levels in relation to patient survival with three demonstrating that increased LC3 is associated with poor overall survival [26,35,36], while two studies found the opposite- increased LC3 corelates with better overall survival [37,38]. The gene discussed is MAP1LC3A; the disease is esophageal squamous cell carcinoma.